Poor and unfortunate timing brought about the selling in NASDAQ:INTU Thursday. Post results the market has drove the stock higher in the after hours Wednesday, as the company beat on earnings and revenue and then raised full year guidance. This rally was short lived as the market had a horrendous day of selling on high volume. If the market stabilises we will...
Today NYSE:AAC made a announcement that pleased investors very much, but despite this, the stock did not rally as it should have due to poor market conditions. The next few days we could get an almighty short squeeze as 28% of the short is sold short. Average Analysts Target Price $4.50 Average Recommendation Overweight Addiction Labs specializes in...
A terrible earnings report added to a weak position for the stock with a large selloff, since then the news flow has improved with the awarding of new contracts and positive commentary from the CEO regarding the strong business relationships that has been built and the prospect of future contracts. The move today was subdued by the weak market sentiment, we...
On Thursday the company announced that certain investors have agreed to purchase approximately $2.8 million of the Company’s common stock in a registered direct offering. The stock had a run but the weakness in the market it sonon pulled back. When we get a good day in the market keep a watch on this stock for a monster move on high volume. The Company entered...
The volume profile in Qrvo is very ugly, massive sell candles with over 100% extra volume each day for the last week,but can we it as capitulation and a sign to step back in to the long side. Given the exposure that NASDAQ:QRVO has to China it is a risky move. We see the $54 area been tested once again, on confirmation of it holding then it is a good time to...
********************MAJOR BREAK POSSIBLE TODAY OUR TARGETS ARE $6.50 AND $10, *****************************
Neovasc a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced on wednesday the 22nd may that the International Journal of Cardiology has published a peer reviewed article regarding long term sustained efficacy and...
NASDAQ:PRTO IS SETTING UP FOR A MONSTER RALLY IN THE COMING DAYS, ALREADY UP 50% THIS WEEK A BREAK ABOVE $.70 COULD RESULT IN A 150% MOVE. lARGE GAP FILL EXIST BELWO THIS LEVEL WITH $3.30 AS THE TARGET GIVING A +300% MOVE. kEEP ON THE WATCHLIST FOR BREAK ABOVE RESISTANCE AT $.70 Short Interest 13% Analysts price target $5 Analysts recommendation HOLD COMPANY...
******Update**** The stock is ready for a major breakout after building strength and establishing a new uptrend,a move above the 200ma could spark a buying frenzy.************************** Company Description vTv Therapeutics , Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small...
******CONTINUATION LOOKS ON THE CARDS TOMORROW, STRONG GAINS THE AFTER HOURS ONCE AGAIN ON GOOV VOLUME. CURRENTLY ON RESISTANCE AT $18 A BREAK COULD BE VERY REWARDING. ***********NEWS FLOW********* The FDA designates Iovance Biotherapeutics' (NASDAQ:IOVA) LN-145 a Breakthrough Therapy for the treatment of recurrent, metastatic, or persistent cervical cancer that...
TNXP looks ready to breakout big today. This low-float Nasdaq listed company could cure PSTD! ======================== TNXP (Tonix Pharmaceuticals Holding Corp.) Alert Price: $1.70 Float: 4.74M Chart Analysis Roth Capital Price Target: $4.00 Investor Presentation Company Website | Recent News ======================== Members, We ask that you...
The stock has had a lovely bounce after filling the gap from post earnings in FEb 19, and is now set for a new run higher with $39, and $42 as conservative targets. Indicators have also reset after hitting oversold territory, combined with renewed buyer interest . Average Price Target $44 Average recommendation Overweight CTRIP.COM INTERNATIONAL LTD....
Those words that no one wants to hear, "Lowers Guidance", in early May it resulted in a massive selloff in what was already a challenging moment for the stock. There is a opportunity here to catch a bounce on the stock at the $42 level for a nice return. Indicators are at a extremely oversold level with at 19 RSI. Average price Target $64 Average...
****Alerts are set for a break above the 12ma which has been blocking the stock action for some days, if it can break this level, it's off to the races for some major gains.Volume has spiked today but that it is just for starters, don't miss out on the next big move. *************** NOVAS THERAPEUTICS INC, DEVELOPS AND SPECIALISES IN DRUGS FOR THE TREATMENT OF...
RETAIL HAS BEEN A NESS THIS WEEK WITH SOME REAL WIDOWMAKER DECLINES IN STOCKS, NYSE:TGT AHS BEEN THE EXCEPTION AND AS NYSE:BBY IS REPORTING TOMORROW MORNING INTO A NEGATIVE MARKET AND A NEGATIVE SECTOR, IT IS A STAY CLEAR FOR THE LONGS SIDE. THE STOCK HAS LOST SOME STEAM AND DESPITE BUYING VOLUME CONTINUING INTO THE REPORT, IT IS OUR OPINION A RISK NOT WORTH...
Copart is a very strong company with financial fundamentals, as earnings approach we are a little worried that the stock is starting to get tired and losing momentum. Indicators are all quite bearish and a break of trend could result in quite a sizeable correction, on the other hand positive results could aid the break above resistance and avoid the dreaded double...
****KEEP THIS NAME ON CLOSE WATCH, SPECULATION ON A GOOGLE PARTNERSHIP COMING TO FRUITION IS NOT BAKED INTO THE STOCK**** Earnings report Highlights Revenues for the three months ended March 31, 2019 decreased by $0.38 million, or 3%, as compared to the three months ended March 31, 2018, mainly because we did not pursue certain low margin, professional services...
****KEEP THIS NAME ON CLOSE WATCH, SPECULATION ON A GOOGLE PARTNERSHIP COMING TO FRUITION IS NOT BAKED INTO THE STOCK**** Earnings report Highlights Revenues for the three months ended March 31, 2019 decreased by $0.38 million, or 3%, as compared to the three months ended March 31, 2018, mainly because we did not pursue certain low margin, professional services...